Revenue Cycle Management

Reimbursement should be a forethought, planned
during assay validation.

Does your institution need help navigating the reimbursement landscape of your NGS project?

Guarantee Financial & Clinical Success


Reimbursement strategy based on region & assay


Planning for Medicare coverage by region


MolDx dossiers & tech assessment support

icon_inferencing rules

Assay launch preparation support


Expert consultation every step of the way

Plan Reimbursement Before Launching Your Program


Expert Consultation

  • Medicare MAC/Payer Mix Analysis
  • Review & Optimize Prior Authorization Workflow
  • Payor Templates: Pre-authorizations, appeals by level, letter of medical necessity
  • Expert Consultation: ICD-10 coding options & CLFS Coding Options by Assay
  • Up to 150 hours of total project support

Collaboration on MolDx Packages & Market Access Dossiers

  • Analytical Validity, Clinical Validation Summary for NGS Solid Tumors or Myeloid Malignancies or Hereditary Germline testing cancer panels
  • Technical Assessment Submission Checklist and Questionnaire
  • Validation Sample Level Data Spreadsheet Master List

Assay Launch Preparation Support

  • Assay Overview, Description & Summary Creation by Assay
  • Patient Financial Assistance Program Review
  • Sub Panels/Disease Specific Tests Review
  • IT/RCM Integration Overview
  • Payor Contracting Review
  • Pricing Review

As NGS-based testing grows, NGS coverage and payment become critical drivers of adoption. 

Clinical Genomics Workspace
Advanced interpretation technology and clinical reporting
Genomic Knowledgebase
Advanced interpretation technology and clinical reporting
Professional Services
Advanced interpretation technology and clinical reporting